OPKO Health, Inc. Available-for-sale Securities, Gross Realized Gains
OPKO Health, Inc. (OPK) reported Available-for-sale Securities, Gross Realized Gains of $1.30 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-02-29.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2016-02-29
- OPKO Health, Inc. available-for-sale securities, gross realized gains for the quarter ending 2014-12-31 was $0.00.
- OPKO Health, Inc. available-for-sale securities, gross realized gains for the quarter ending 2014-09-30 was $0.00.
- OPKO Health, Inc. available-for-sale securities, gross realized gains for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. available-for-sale securities, gross realized gains for the quarter ending 2014-03-31 was $1.30M, a 43.48% decline year-over-year.
- OPKO Health, Inc. available-for-sale securities, gross realized gains for fiscal 2014 was $1.30M, a 87.96% decline from fiscal 2013.
- OPKO Health, Inc. available-for-sale securities, gross realized gains for fiscal 2013 was $10.80M.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 9 month | Available-for-sale Securities, Gross Realized Gains 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $1.30M 10-K · filed 2016-02-29 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $1.30M 10-Q · filed 2014-11-07 | $1.30M derived: sum of 4 quarters · filed 2015-02-27 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.30M 10-Q · filed 2014-08-11 | $1.30M derived: sum of 3 quarters · filed 2015-02-27 | $1.30M derived: sum of 4 quarters · filed 2015-02-27 |
| 2014-03-31 | $1.30M 10-Q · filed 2014-05-09 | $1.30M derived: sum of 2 quarters · filed 2015-02-27 | $1.30M derived: sum of 3 quarters · filed 2015-02-27 | $9.80M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $8.50M derived: sum of 3 quarters · filed 2015-02-27 | $10.80M 10-K · filed 2015-02-27 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $8.50M derived: sum of 2 quarters · filed 2013-11-12 | $10.80M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $8.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $10.80M 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | $2.30M 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |